Horizon Discovery Group plc
Horizon powers genomic research and translational medicine from sequence to treatment.
Horizon Discovery is a UK Biotechnology company founded in 2007, and built upon a 20 year heritage in oncology research, translational medicine and gene-editing. The company’s unique history and experience has culminated in a precision gene-editing platform that incorporates rAAV, CRISPR and ZFN technologies. Horizon is the only company that has access to such a broad range of tools, allowing any genome modification challenge to be addressed.